Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Compound 2
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
SARS-CoV-2 saRNA LNP vaccine
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/25/2020
Cidofovir diphosphate
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
2’-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
Biotin-16-dUTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
3′-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
MI-432
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020
MI-1900
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020
MI-1851
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020
Resiniferatoxin 
Potential treatment - theoretical effect Experimental Other treatment Apr/04/2020
candidate vaccine (Sanofi + GSK)
Potential treatment - clinical evidence Experimental Vaccine Mar/26/2020
ZyCoV-D
Emergency use authorization Experimental Vaccine Mar/26/2020
LUNAR-COV19
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
Candidate vaccine
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020
SCB-2019
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020
LNP-nCoVsaRNA
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020
CVnCoV
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020